Speakers
Clinicians
Stephen Chris Pappas, MD, Director, Clinical Research; St. Luke's Texas Liver Institute
John R Richert, MD, EVP for Research & Clinical Programs; National MS Society
Stephen Frisbane, MD, Professor of Medicine; State University of New York at Stony Brook School of Medicine
Chaim Charyan, MD, Chief of the Renal Division; New York Hospital Medical Center of Queens
Douglas Dieterich, MD, Professor of Medicine; Mount Sinai School of Medicine
Barbara Burton, MD, Director, PKU Program; Professor of Pediatrics; Northwestern University's Feinberg School of Medicine
Chester Whitley, MD, Professor, Gene Therapy Center; University of Minnesota
Michael Becker, MD, Professor of Medicine; University of Chicago School of Medicine
Gary Schwartz, MD, Chief, Melanoma and Sarcoma Service; Memorial Sloan Kettering Cancer Center
Mark Tullman, MD, Director, Multiple Sclerosis Clinical Care and Research Center; Columbia University Medical Center
Allan Gibofsky, MD, JD, Professor of Medicine; Weill Medical College of Cornell University
Jeffrey Bennett, MD, PhD, Associate Professor of Neurology and Opthamology; Rocky Mountain Multiple Sclerosis Center at the Anshutz Medical Campus, University of Colorado Denver, Aurora, CO.
Thomas Leist, MD, PhD, Director; Neuroimmunology & Comprehensive MS Center; Thomas Jefferson University
Anna C. Pavlick, Asst Professor of Medicine and Dermatology; NYU School of Medicine
Donna Ryan, Associate Executive Director, Clinical Research; Pennington Biomedical Research Center
Allan Gibofsky, MD, JD, Professor of Medicine and Public Health and Co-Director of the Center of Biologic Therapy at the Weill Medical College of Cornell University in New York; Adjunct Professor of Law, Fordham University School of Law; Attending Rheumatologist, Hospital for Special Surgery and New York Presbyterian Hospital
Harold Bays, MD, FACE, FACP, Medical Director and President; Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
Analysts
Salveen Kochnover, CFA, Senior Analyst, Biotechnology Equity Research; Collins Stewart, LLC
Kimberly Lee, DO, Senior Healthcare Research Analyst; Wedbush Pacific Growth Life Sciences
Mark Schoenbaum, MD, Managing Director & Senior Analyst-Biotechnology; Deutsche Bank Securities, LLC
Benjamin R. Bowen, Ph.D., Director of Investment Banking; Rodman & Renshaw
Liana Moussatos, PhD, Senior Healthcare Research Analyst; Wedbush Pacific Growth Life Sciences
Eric Schmidt, PhD, Managing Director; Cowen & Company
Benjamin J Davey, Managing Director, Head of Equire Capital Markets; Wedbush Pacific Growth Life Sciences
Jason Kolbert, Managing Director, Research; ThinkEquity, LLC
Mike King, Head of Healthcare & Sr Managing Director; Rodman and Renshaw
Michelle Easton, Partner; Tarplin & Young
Scott Gottlieb, Resident Fellow; The American Enterprise Institute
Robert Rynd, Director, Corporate Advistory Services; Thomson Reuters
Ben Bonifant, VP, Business Development; Campbell Alliance
Ben Perkins, Managing Director; Wedbush Pacific Growth Life Sciences
Richard Gervase, Member; Mintz Levin
Michael Herman, SVP, Royalty Investments; Royalty Pharma
Greg Brown, Managing Director; Cowen Healthcare Royalty Partners
William Reiland, Managing Director; Leerink Swann
Glen Giovannetti, Global Biotechnology Leader; Ernst & Young
Eric Roberts, Managing Director; Caxton Advantage Venture Partners
Oleg Nodelman, Portfolio Manager and Partner; Biotechnology Value Fund
Kris H. Jenner, M.D., D. Phil, Portfolio Manager; T. Rowe Price
Industry
Eugenia Shen, Sr Manager, Investor Relations; BioMarin Pharmaceutical Inc.
Daniel P. Maher, Vice President, Product Development; BioMarin Pharmaceutical Inc.
Brian JG Pereira, MD, President and CEO; AMAG Pharmaceuticals, Inc.
Raymond P Warrell, Jr., MD, Chairman of the Boad & CEO; Genta Incorporated
Dennis Kim, MD, Sr. Vice President, Head of Obesity and Metabolic Diseases; Orexigen Therapeutics, Inc.
Anne-Marie Duilege, MD, MS, Chief Medical Officer; Affymax, Inc.
Michelle Dipp, MD, PhD, VP Corporate Development; Head, US CEEDD; Sirtris & GlaxoSmithKline
John Craighead, Ph.D., Director, IR & BD; BIO
Barry D. Quart, PharmD, President, CEO, and Director; Ardea Biosciences
Safi R. Bahcall, PhD, President and Chief Executive Officer; Synta Pharmaceuticals Corp.
Stephen T Worland, PhD, President and CEO; Anadys Pharmaceuticals, Inc.
Wesley Day, PhD, Vice President of Clinical Development; VIVUS, Inc.
J. Donald deBethizy, PhD, President and CEO; Targacept, Inc.
Garry Menzel, PhD, EVP, Corporate Development & Finance; Regulus Therapeutics
Mark Leuchtenberger, President and CEO; Targanta Therapeutics Corporation
James C. Greenwood, President and CEO; BIO
Robert J. Terifay, Sr VP, Commercial; Regeneron Pharmaceuticals Inc.
Geoffrey M. Nichol, Sr VP, Product Development; Medarex Inc.
Jack Lief, Co-Founder, President and CEO; Arena Pharmaceuticals, Inc.
Barry Labinger, EVP & CCO; Human Genome Sciences
Sylvie Gregoire, President; Shire Human Genetic Therapies
Fran Heller, Executive Vice President, Business Development; Exelixis, Inc.
Barbara Yanni, Vice President and Chief Licensing Officer; Merck & Co., Inc.
Perry Karsen, Head of Worldwide Business Development; Celgene Corporation
Bill Ringo, Sr, Vice President, Strategy and Business Development; Pfizer Inc.
Jeremy Levin, Senior Vice President, Strategic Transactions; Bristol-Myers Squibb Co.
Damien McDevitt, VP and Head of Drug Discovery Transactions; GlaxoSmithKline
Drew Fromkin, President & CEO; Clinical Data, Inc.
Steve Usdin, Washington Editor; BioCentury Publications, Inc.
Daniel P. Maher, Vice President, Product Development; BioMarin Pharmaceuticals Inc.
Dennis Kim, M.D., MBA, Senior Vice President, Head of Obesity and Metabolic Diseases; Orexigen Therapeutics Inc.
Timothy E. Morris, Chief Financial Officer and Divisional Vice President; Vivus, Incorporated